<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the role of the Ala45Thr variant of BETA2/NEUROD1 in the development of type 1 or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we studied a Japanese population consisting of 383 control subjects, 234 type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and 160 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients </plain></SENT>
<SENT sid="1" pm="."><plain>Both genotypewise and allelewise, there was no significant association of the variant with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Japanese </plain></SENT>
<SENT sid="2" pm="."><plain>Also, there were no significant differences in clinical characteristics with and without the variant </plain></SENT>
<SENT sid="3" pm="."><plain>Our present results do not support a recent report which described an association of the Ala45Thr variant with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> in Japanese </plain></SENT>
</text></document>